lactic acid and lopinavir

lactic acid has been researched along with lopinavir in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	4 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Aweeka, F; Grunfeld, C; Lee, GA; Lo, JC; Mulligan, K; Rao, M; Schambelan, M; Schwarz, JM	1
Belgum, T; Christensen, K; Dash, A; Destache, CJ; Sharma, A; Shibata, A	1
Belshan, M; Date, AA; Destache, CJ; Goede, M; McMullen, E; Pham, A; Sanford, B; Shibata, A; Zhou, Y	1
Joshi, G; Kumar, A; Sawant, K	1
Abou-El-Naga, IF; El Kerdany, ED; Mady, RF; Shalaby, TI; Zaytoun, EM	1

Trials

1 trial(s) available for lactic acid and lopinavir

Article	Year
Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS (London, England), 2007, Oct-18, Volume: 21, Issue:16 Topics: Adult; Aged; Blood Glucose; Carbamates; Double-Blind Method; Energy Metabolism; Furans; Glucose Clamp Technique; HIV Protease Inhibitors; Humans; Indinavir; Insulin; Insulin Resistance; Lactic Acid; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Sulfonamides	2007

Article

Year

Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.

AIDS (London, England), 2007, Oct-18, Volume: 21, Issue:16

Topics: Adult; Aged; Blood Glucose; Carbamates; Double-Blind Method; Energy Metabolism; Furans; Glucose Clamp Technique; HIV Protease Inhibitors; Humans; Indinavir; Insulin; Insulin Resistance; Lactic Acid; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Sulfonamides

2007

Other Studies

5 other study(ies) available for lactic acid and lopinavir

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1. BMC infectious diseases, 2009, Dec-09, Volume: 9 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Carriers; Drug Combinations; Drug Compounding; HIV Infections; Humans; Lactic Acid; Lopinavir; Macrophages; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidinones; Ritonavir	2009
Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment. AIDS research and human retroviruses, 2013, Volume: 29, Issue:5 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4-Positive T-Lymphocytes; Cell Line; Cell Survival; Cyclopropanes; Drug Therapy, Combination; HeLa Cells; HIV Infections; HIV-1; Humans; Lactic Acid; Lopinavir; Microscopy, Confocal; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Subcellular Fractions; U937 Cells	2013
Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles. Drug delivery, 2016, Volume: 23, Issue:9 Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Humans; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Lopinavir; Male; Nanoparticles; Particle Size; Permeability; Peyer's Patches; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar	2016
The effect of lopinavir/ritonavir and lopinavir/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis. Parasitology international, 2017, Volume: 66, Issue:6 Topics: Animals; Coccidiostats; Drug Combinations; HIV Protease Inhibitors; Lactic Acid; Lopinavir; Male; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Ritonavir; Toxoplasmosis, Animal	2017